drugset / Trial / NCT03105505

The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis

NCT03105505

Phase 4 Unknown 75 enrolled Barzilai Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The study aims to investigate the effect of Permethrin 5% treatment on Signs and symptoms of Demodex-blepharitis in comparison to Synthomycine 5% and Fucithalmic (fusidic acid 1%) .

Timeline

Start
2017-04-28
Primary completion
2018-09
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fusidic Acid Unknown 1 % Topical
Comparator Permethrin Small molecule 5 % Topical
Comparator chloramphenicol Small molecule 5 % Topical

Indications